輸入代號或公司名稱後按 Enter
4745

合富-KY

-0.05 (-0.43%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
11.7021成交張數本益比0.27股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.35-3.24-0.25-2.9%-0.88%-9.63%
2026Q1-0.40-3.19-0.31-4.4%-1.08%-8.63%
2025Q4-2.07-2687.5%-3.18-1.61-28.1%-5.91%-8.70%
2025Q3-0.42-1.03-0.32-4.1%-1.27%-2.97%
2025Q2-0.30-0.68-0.24-2.9%-0.89%-2.05%
2025Q1-0.39-657.1%-0.45-0.30-3.8%-1.08%-1.25%
2024Q40.080.010.060.6%0.22%0.02%
2024Q3-0.07-130.4%-0.16-0.06-0.6%-0.21%-0.44%
2024Q2-0.07-150.0%0.14-0.05-0.4%-0.18%0.42%
2024Q10.07-80.0%0.350.050.5%0.19%0.97%
2023Q4-0.09-126.5%0.63-0.07-0.6%-0.24%1.77%
2023Q30.2315.0%1.060.181.5%0.65%2.90%
2023Q20.14-60.0%1.030.110.8%0.39%2.89%
2023Q10.356.1%1.240.272.3%0.95%3.28%
2022Q40.34-46.0%1.220.261.8%0.91%3.48%
2022Q30.20-31.0%1.510.161.1%0.55%4.38%
2022Q20.35-39.7%1.600.271.9%0.94%4.59%
2022Q10.3310.0%1.830.261.9%0.94%5.18%
2021Q40.631475.0%1.800.493.9%1.93%5.46%
2021Q30.2920.8%1.210.221.7%0.87%3.74%
2021Q20.58-50.7%1.160.453.1%1.75%3.56%
2021Q10.3096.9%1.760.232.1%0.92%5.45%
2020Q40.04-90.0%1.610.030.2%0.11%4.99%
2020Q30.2468.0%1.970.181.7%0.74%6.16%
2020Q21.18-54.7%1.870.916.8%3.74%7.49%
2020Q10.15-67.5%3.290.121.4%0.48%11.74%
2019Q40.40-43.4%3.610.312.7%1.26%13.09%
2019Q30.14-79.8%3.920.514.7%2.05%13.99%
2019Q22.6043.7%4.481.6211.9%7.36%14.14%
2019Q10.4722.5%3.690.363.3%1.93%16.05%
2018Q40.7115.2%3.600.555.6%2.94%16.38%
2018Q30.7188.3%3.510.575.4%3.00%16.02%
2018Q21.81125.8%3.181.4514.5%8.01%14.70%
2018Q10.380.0%2.170.313.5%1.80%10.47%
2017Q40.61-4.5%2.170.495.8%2.98%10.69%
2017Q30.382.0%2.200.303.9%1.87%10.92%
2017Q20.8048.0%2.190.648.9%4.05%11.01%
2017Q10.38-41.1%1.930.314.4%1.93%9.26%
2016Q40.642.200.516.7%3.22%
2016Q30.370.304.3%1.85%